Lifecore Biomedical (LFCR) EPS (2011 - 2026)
Lifecore Biomedical (LFCR) EPS from May 29, 2011 to Mar 31, 2026. The TTM Lifecore Biomedical (LFCR) EPS is -$1.10. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Lifecore Biomedical (LFCR) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -47.70% |
| 3 Years TTM | -29.59% |
| 5 Years TTM | -1.37% |
| 10 Years TTM | +4.51% |
Annual EPS change of Lifecore Biomedical (LFCR)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.40 | +417.47% |
| 2025 | -$0.08 | -119.66% |
| 2024 | $0.39 | -132.62% |
| 2023 | -$1.20 | +178.44% |
| 2022 | -$0.43 | -60.69% |
| 2021 | -$1.10 | +177.38% |
| 2020 | -$0.40 | -1127.45% |
| 2019 | $0.04 | -284.48% |
| 2018 | -$0.02 | -217.50% |
| 2017 | $0.02 | -63.63% |
| 2016 | $0.05 | -29.57% |
| 2015 | $0.07 | -42.07% |
| 2014 | $0.12 | -85.97% |
| 2013 | $0.86 | +72.77% |
| 2012 | $0.50 | +233.60% |
| 2011 | $0.15 | N/A |
Comparison Lifecore Biomedical (LFCR) five years EPS CAGR with competitors
Lifecore Biomedical (LFCR) five years EPS CAGR is 16.09%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 101.37% | +529.94% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.58% | +77.61% |
| RGC | Regencell Bioscience Holdings Ltd | 27.66% | +71.88% |
| UTHR | United Therapeutics Corp | 26.56% | +65.05% |
| ANIP | ANI Pharmaceuticals Inc | 25.74% | +59.97% |
| PAHC | Phibro Animal Health Corp - Class A | 15.27% | -5.10% |
| ZTS | Zoetis Inc - Class A | 10.56% | -34.39% |
| NBIX | Neurocrine Biosciences Inc | 9.25% | -42.50% |
| PBH | Prestige Consumer Healthcare Inc | 8.18% | -49.16% |
| BCRX | Biocryst Pharmaceuticals Inc | 6.24% | -61.22% |
| BHC | Bausch Health Companies Inc | 2.51% | -84.39% |
| RDY | Dr. Reddy`s Laboratories Ltd | 2.45% | -84.79% |
| YCBD | cbdMD Inc | 1.50% | -90.68% |